A majority of outside advisers for the FDA voted Thursday in support of allowing pharmacies to compound the first four of seven unapproved peptides.

A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular…

An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.